1. Aseptic Workflow Solution
a n i n n o v a t i v e s o l u t i o n
MEDCURA™
PHARMACEUTICAL
COMPOUNDING MANAGEMENT
SYSTEM
COLOUR LABELS
Medcura™ provides a wide range of customisable colour label
templates, designed to fit various container sizes. The system
intelligently selects the correct label template based on the final
container size.
Each label printed has a unique bar-code which means each
individual product can be track and traced and recalled if required.
A wide range of bar-code types could be placed on the label
including GS1 2D Matrix bar-codes.
BOOK A DEMO
To request additional information, including a live Medcura™
system demonstration, please contact us.
Medcura Technologies ltd
Coxbridge Innovation Park
A2 Endeavour Place
Farnham, GU10 5EH
info@medcura.co.uk
www.medcura.co.uk
+44 1252 821 835 tel

2. MEDCURA™ - ENABLING SMARTER PHARMACY
OUR MISSION
At Medcura Technologies, we are focused on enabling smarter
pharmacy. We created Medcura™ because we knew that
innovative technology can provide a better way to compound
IV products. A modern IT solution that significantly reduces
errors, saves money by cutting drug wastage and enhances
pharmacy productivity.
T h e c h a l l e n g e s
ERRORS AND PATIENT SAFETY
A compounding service which relies upon human checking for the quality
assurance of the products produced is prone to error. These errors create
four main categories of risk:
- Harm to patients
- Harm to the product with subsequent impact on patient
- Disruption to the service
- Harm to staff
Medcura™ prevents errors by preventing:
- Wrong drug
- Wrong dose
- Wrong patient
- Wrong label
- Wrong technique
DRUG WASTAGE
The IV compounding process generates drug waste which can be
prevented. Waste can result from expiration, disposal of partially used
active ingredients, returned patient-specific drugs and wrongly prepared
doses. With more and more high cost chemotherapy drugs being used,
the ability to reduce drug wastage can provide a significant financial
saving for the hospital. There is good evidence to show that electronic
management systems like Medcura™ can be put in place to reduce this
drug wastage.
SERVICE PRESSURES
Demand for IV chemotherapy is forecasted to increase by 7-10% per
annum year on year. More patients and more intricate treatment regimens
lead to increased demand on pharmacy, translating into significant
resource pressures, causing more errors and the potential for prolonged
patient wait times and dissatisfaction. By providing visibility and control
over the entire dose preparation process, for both patient specific and
batch doses, the Medcura™ workflow system is able to enhance pharmacy
productivity.
F e a t u r e s a n d B e n e f i t s
PRODUCT RANGE
The Medcura™ system is designed to cater for a wide range of IV aseptic
product types. Product categories include Chemotherapy, MABs, CIVAS,
Clinical Trials, products with a single drugs or multiple drugs, for patient
specific or batch production. The system is flexible and supports many
final containers; syringes, infusion bag, elastomeric devices, drops & oral
solutions.
S e r i o u s M e d i c i n e ,
S m a r t P h a r m a c y ,
E x t r a o r d i n a r y C a r e
Medcura™ is built on moren
cloud technology. It is truly
browser based and can be
accessed on a variety of
mobile devices.
“With good stability data and very strong process control in
Medcura, a “part used vial” policy for high cost drugs could
make a compelling business case” Dr. Shapour Hariri, CEO,
Medcura Technologies
“At UHS we see
Medcura as one
of the key ways
we can ensure our
patients receive a
Chemotherapy service
that is safe and of
the highest possible
quality.”
Sue Ladds
Chief Pharmacist
Southampton Hospital
AUTOMATED CALCULATIONS
The system provides the full range of compounding calculations, including drug vol, diluent vol, measurement syringe, removal
volume, overages, reconstitution, container size selection, final container dose split and double dilution. All dose volume rounding
is based on measurement syringe accuracy tables and is validated against the dose accuracy policy of the aseptic unit. Stability
is calculated based on final drug concentrations. Short expiry products are automatically scheduled in a timely manner to ensure
stability for patient administration.
RAW MATERIAL CONTROL
A key aspect of reducing risk in compounding is to control the raw materials that are used in the process. Medcura™ controls
the receipt, QC, storage and final utilisation of all raw materials including, drug products, diluents, devices, containers and
consumables. Control is achieved through bar-code and batch number / expiry date identification through out the compounding
process. This modules is also able to keep live stock data and run algorithms to allocate the most cost effective vial size for each
order or group of orders.
REDUCING DRUG BUDGET
Vial sharing and use of part used vials are two areas where aseptic units could save costs. Medcura™ provides comprehensive
software control using bar-codes, tracking vials and monitoring storage conditions. With these safe controls in place the aseptic
unit can implement a drug waste reduction policy.
ELECTRONIC COMPOUNDING
For organisations that no longer wish to use worksheets and labels, Medcura™
Offers a fully electronic compounding solution. All process steps, Scheduling
Allocation, Picking, Compounding, Inspection, Release, Delivery and
Administration are controlled in an electronic workflow. This provides very
effective control and significantly reduces operator errors.
INTEGRATION
Medcura Technologies Ltd is committed to integrating the healthcare enterprise
by using open standards exchange of healthcare data amongst health information
systems. Medcura uses dm+d and SNOMED CT to encode its content and provides
HL7 interfaces for interfacing with e-prescribing, Pharmacy and PAS systems.
SECURITY, AUDIT AND COMPLIANCE
The system tracks every user transaction and has a robust version control,
allowing a very detailed batch record documentation to be made available. This
makes investigating incidence easier and greatly helps with GMP and MHRA
compliance.